B7.1 and B7.2 co-stimulatory molecules regulate crescentic glomerulonephritis

European Journal of Immunology

Volumn 30, Issue 5, 2000, Pages 1394-1401

  Li, Shuo ^a   Holdsworth, Stephen R ^a   Tipping, Peter G ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

B7.1; B7.2; Co stimulation; Glomerulonephritis; Mouse

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; GLOMERULONEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SKIN ALLERGY; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CYTOKINES; GLOMERULONEPHRITIS; MEMBRANE GLYCOPROTEINS; MICE; RECEPTORS, ANTIGEN, T-CELL; SHEEP; T-LYMPHOCYTE SUBSETS;

EID: 0034023394     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(200005)30:5<1394::AID-IMMU1394>3.0.CO;2-O     Document Type: Article

References (37)

1. Chambers, C. A., Cado, D., Truong, T. and Allison, J. P., Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl. Acad. Sci. USA 1997. 94: 9296-9301.
2. Mueller, D. L. and Jenkins, M. K., Molecular mechanisms underlying functional T-cell unresponsiveness. Curr. Opin. Immunol. 1995. 7: 375-381.
3. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A., CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996. 14: 233-258.
4. Tivol, E. A., Schweitzer, A. N. and Sharpe, A. H., Costimulation and autoimmunity. Curr. Opin. Immunol. 1996. 8: 822-830.
5. June, C. H., Bluestone, J. A., Nadler, L. M. and Thompson, C. B., The B7 and CD28 receptor families. Immunol. Today 1994. 15: 321-331.
6. Janeway, C. A., Jr. and Bottomly, K., Signals and signs for lymphocyte responses. Cell 1994. 76: 275-285.
7. Lenschow, D. J. and Bluestone, J. A., T cell co-stimulation and in vivo tolerance. Curr. Opin. Immunol. 1993. 5: 747-752.
8. Schwartz, R. H., Mueller, D. L., Jenkins, M. K. and Quill, H., T-cell clonal anergy. Cold Spring Harb. Symp. Quant. Biol. 1989. 54: 605-610.
9. Borriello, F., Sethna, M. P., Boyd, S. D., Schweitzer, A. N., Tivol, E. A., Jacoby, D., Strom, T. B., Simpson, E. M., Freeman, G. J. and Sharpe, A. H., B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997. 6: 303-313.
10. Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M., Ke, X. Y., Rennert, P. D., Gray, G. S., Gribben, J. G. and Nadler, L. M., B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995. 2: 523-532.
11. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H. and Mak, T. W., Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995. 270: 985-988.
12. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H., Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995. 3: 541-547.
13. Krummel, M. F. and Allison, J. P., CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 1996. 183: 2533-2540.
14. Thompson, C. B. and Allison, J. P., The emerging role of CTLA-4 as an immune attenuator. Immunity 1997. 7: 445-450.
15. Lenschow, D. J., Herold, K. C., Rhee, L., Patel, B., Koons, A., Qin, H. Y., Fuchs, E., Singh, B., Thomspon, C. B. and Bluestone, J. A., CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 1996. 5: 285-293.
16. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N. and Glimcher, L. H., B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995. 80: 707-718.
17. Racke, M. K., Scott, D. E., Quigley, L., Gray, G. S., Abe, R., June, C. H. and Perrin, P. J., Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 1995. 96: 2195-2203.
18. Chang, T. T., Jabs, C., Soble, R. A., Kuchroo, V. K. and Sharpe, A. H., Studies in B7-deficient mice reveal a critical role of B7 costimulation in both induction and effector phases of experimental autoimmune encephalitis. J. Exp. Med. 1999. 190: 733-740.
19. Girvin, A. M., Dal Canto, M. C., Rhee, L., Salomon, B., Sharpe, A., Bluestone, J. A. and Miller, S. D., A critical role for B7/CD28 costimulation in experimental autoimmune encephalitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. J. Immunol. 2000. 164: 136-143.
20. Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C. and Bluestone, J. A., Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment of the development of diabetes in the non-obese diabetic mouse. J. Exp. Med. 1995. 181: 1145-1155.
21. Lenschow, D. J., Zeng, Y., Hathcock, K. S., Zuckerman, L. A., Freeman, G., Thistlethwaite, J. R., Gray, G. S., Hodes, R. J. and Bluestone, J. A., Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 1995. 60: 1171-1178.
22. Cunningham, M. A., Huang, X. R., Dowling, J. P., Tipping, P. G. and Holdsworth, S. R., Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J. Am. Soc. Nephrol. 1999. 10: 499-506.
23. Huang, X. R., Tipping, P. G., Apostolopoulos, J., Oettinger, C., D'Souza, M., Milton, G. and Holdsworth, S. R., Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin. Exp. Immunol. 1997. 109: 134-142.
24. Holdsworth, S. R. and Tipping, P. G., Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. J. Clin. Invest. 1985. 76: 1367-1374.
25. Li, S., Holdsworth, S. R. and Tipping, P. G., Antibody independent crescentic glomerulonephritis in mu chain deficient mice. Kidney Int. 1997. 51: 672-678.
26. Kitching, A. R., Tipping, P. G., Mutch, D. A., Huang, X. R. and Holdsworth, S. R., Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. Kidney Int. 1998. 53: 112-118.
27. Tipping, P. G., Kitching, A. R., Huang, X. R., Mutch, D. A. and Holdsworth, S. R., Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur. J. Immunol. 1997. 27: 530-537.
28. Kitching, A. R., Tipping, P. G. and Holdsworth, S. R., IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur. J. Immunol. 1999. 29: 1-10.
29. Peterson, K. E., Sharp, G. C., Tang, H. and Braley-Mullen, H., B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis. J. Immunol. 1999. 162: 1859-1867.
30. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Hathcock, K. S., Laszlo, G., McKnight, A. J., Kim, J., Du, L. and Lombard, D. B., Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 1993. 262: 907-909.
31. Nakajima, A., Azuma, M., Kodera, S., Nuriya, S., Terashi, A., Abe, M., Hirose, S., Shirai, T., Yagita, H. and Okumura, K., Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur. J. Immunol. 1995. 25: 3060-3069.
32. Tran, H. M., Nickerson, P. W., Restifo, A. C., Ivis-Woodward, M. A., Patel, A., Allen, R. D., Strom, T. B. and O'Connell, P. J., Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. J. Immunol. 1997. 159: 2232-2239.
33. Takiguchi, M., Murakami, M., Nakagawa, I., Yamada, A., Chikuma, S., Kawaguchi, Y., Hashimoto, A. and Uede, T., Blockade of CD28/CTLA4-B7 pathway prevented autoantibody-related disease but not lung disease in MRL/lpr mice. Lab. Invest. 1999. 79: 317-326.
34. Huang, X. R., Holdsworth, S. R. and Tipping, P. G., Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int. 1994. 46: 69-78.
35. Li, S., Kurts, C., Kontgen, F., Holdsworth, S. R. and Tipping, P. G., Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. J. Exp. Med. 1998. 188: 597-602.
36. Razi-Wolf, Z., Falo, L. D., Jr. and Reiser, H., Expression and function of the costimulatory molecule B7 on murine Langerhans cells: evidence for an alternative CTLA-4 ligand. Eur. J. Immunol. 1994. 24: 805-811.
37. Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A. Jr., Lombard, L. A., Gray, G. S. and Nadler, L. M., Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993. 262: 909-911.